Page last updated: 2024-08-23

taurolidine and Skin Neoplasms

taurolidine has been researched along with Skin Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baumann, K; Dummer, R; French, LE; Goldinger, SM; Imhof, L; Röthlisberger, P; Schad, K1
Gong, SL; Liu, LL; Redmond, HP; Sun, BS; Wang, JH1

Trials

1 trial(s) available for taurolidine and Skin Neoplasms

ArticleYear
The antibacterial substance, taurolidine in the second/third-line treatment of very advanced stage IV melanoma including brain metastases: results of a phase 2, open-label study.
    Melanoma research, 2011, Volume: 21, Issue:1

    Topics: Adult; Aged; Anti-Infective Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Disease Progression; Female; Humans; Infusions, Intravenous; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prospective Studies; Skin Neoplasms; Taurine; Thiadiazines; Treatment Outcome

2011

Other Studies

1 other study(ies) available for taurolidine and Skin Neoplasms

ArticleYear
Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins.
    Journal of surgical oncology, 2007, Sep-01, Volume: 96, Issue:3

    Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; In Situ Nick-End Labeling; Injections, Intraperitoneal; Maximum Tolerated Dose; Melanoma; Mice; Mice, Inbred C57BL; Skin Neoplasms; Taurine; Thiadiazines; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2007